
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [NVAX] Novavax Inc
Data updated 2025-May-16 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-May-16 Friday
Open | $6.33 | High | $6.89 +8.85% |
---|---|---|---|
Close | $6.73 | Low | $6.33 0.00% |
Volume | 8.73 Million 0.72x | Volatility | 8.85% |
Change |
+$0.44
+7.00%
|
Streak | ↑ 2 days +12.92% |
20d SMA | $6.43 +4.7% | 50d SMA | $6.80 -1.0% | 100d SMA | $7.63 -11.8% | 200d SMA | $9.25 -27.3% |
RSI | 53 | MACD | 0.04 | ADX | 10.6 | Stochastic Oscillator | 31.0 23.7 |
CCI | 40.7 | ATR | 0.57 | OBV | 544 Million | Chaikin A/D | -418 Million |
Market Cap | 620 M | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 0.8 | Price/Book (mrq) | EV/Revenue (ttm) | 0.5 | EV/EBITDA (ttm) | -0.58 | |
% Held by Insiders | 4.99% | % Held by Institutions | 56.32% | Shares Short | 48.1 M | Shares Short (prior month) | 54.8 M |
Short Ratio | 4.04 | Short % of Outstanding | 34.39% | Short % of Float | 38.44% | Shares Short Change (mom) | -12.2% |
Revenue/Share (ttm) | $9.76 | Profit Margin (ttm) | -55.41% | Operating Margin (ttm) | -63.01% | EBITDA (ttm) | -511 M |
Diluted EPS (ttm) | $-5.41 | Current Ratio (mrq) | 0.7 | Return on Assets (ttm) | -17.02% | Return on Equity (ttm) | |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | -18.50% | Operating Cash Flow (ttm) | -714 M | Free Cash Flow (ttm) | -979 M | |
Choose view type
Daily Performance for Novavax Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Novavax Inc up to close of 2025-May-16 at $6.73
2-week Performance Benchmarks for Novavax Inc:
Related to Novavax Inc
Information for Novavax Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-16 on Google
SEC Reports : Quarterly reports around 2025-May-16 on SEC Edgar
Compare Novavax Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Novavax Inc
Industry : Biotechnology industry performance which includes Novavax Inc